Temozolomide sensitizes MGMT-deficient tumor cells to ATR inhibitors

Christopher B. Jackson, Seth I. Noorbakhsh, Ranjini K. Sundaram, Aravind N. Kalathil, Sachita Ganesa, Lanqi Jia, Hank Breslin, Danielle M. Burgenske, Oren Gilad, Jann N. Sarkaria, Ranjit S. Bindra

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Temozolomide sensitizes MGMT-deficient tumor cells to ATR inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences